Cellebrite DI Ltd [NASDAQ: CLBT] gained 20.73% on the last trading session, reaching $19.28 price per share at the time.
Cellebrite DI Ltd represents 239.47 million in outstanding shares, while the company has a total market value of $4.62 billion with the latest information. CLBT stock price has been found in the range of $18.204 to $19.98.
If compared to the average trading volume of 1.78M shares, CLBT reached a trading volume of 4995320 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Cellebrite DI Ltd [CLBT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLBT shares is $24.71 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLBT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Cellebrite DI Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 28, 2024. The new note on the price target was released on March 13, 2024, representing the official price target for Cellebrite DI Ltd stock. Previously, the target price had yet another raise from $9 to $12, while BofA Securities kept a Buy rating on CLBT stock.
The Price to Book ratio for the last quarter was 11.30, with the Price to Cash per share for the same quarter was set at 2.20. Price to Free Cash Flow for CLBT in the course of the last twelve months was 32.92 with Quick ratio for the last quarter at 2.08.
Trading performance analysis for CLBT stock
Cellebrite DI Ltd [CLBT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 26.34. With this latest performance, CLBT shares dropped by -0.10% in over the last four-week period, additionally plugging by 11.64% over the last 6 months – not to mention a drop of -12.48% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLBT stock in for the last two-week period is set at 64.57, with the RSI for the last a single of trading hit 0.94, and the three-weeks RSI is set at 0.76 for Cellebrite DI Ltd [CLBT]. The present Moving Average for the last 50 days of trading for this stock 17.78, while it was recorded at 16.39 for the last single week of trading, and 17.67 for the last 200 days.
Cellebrite DI Ltd [CLBT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Cellebrite DI Ltd [CLBT] shares currently have an operating margin of 13.96% and a Gross Margin at 83.96%. Cellebrite DI Ltd’s Net Margin is presently recorded at 16.74%.
Cellebrite DI Ltd (CLBT) Capital Structure & Debt Analysis
According to recent financial data for Cellebrite DI Ltd. ( CLBT), the Return on Equity (ROE) stands at 20.46%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 10.43%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Cellebrite DI Ltd’s Return on Invested Capital (ROIC) is 16.40%, showcasing its effectiveness in deploying capital for earnings.
Cellebrite DI Ltd (CLBT) Efficiency & Liquidity Metrics
Based on Cellebrite DI Ltd’s (CLBT) latest financial statements, the Debt-to-Equity Ratio is 0.05%, indicating its reliance on debt financing relative to shareholder equity.
Cellebrite DI Ltd (CLBT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Cellebrite DI Ltd. (CLBT) effectively leverages its workforce, generating an average of $65407.03 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.11% and a Quick Ratio of 2.08%, indicating strong ability to cover short-term liabilities.
Cellebrite DI Ltd [CLBT]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Cellebrite DI Ltd posted 0.1/share EPS, while the average EPS was predicted by analysts to be reported at 0.1/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLBT.
An analysis of Institutional ownership at Cellebrite DI Ltd [CLBT]
There are presently around $51.42%, or 89.57%% of CLBT stock, in the hands of institutional investors. The top three institutional holders of CLBT stocks are: TRUE WIND CAPITAL MANAGEMENT, L.P. with ownership of 13.39 million shares, which is approximately 6.7291%. CLAL INSURANCE ENTERPRISES HOLDINGS LTD, holding 7.65 million shares of the stock with an approximate value of $$91.47 million in CLBT stocks shares; and CLAL INSURANCE ENTERPRISES HOLDINGS LTD, currently with $$83.54 million in CLBT stock with ownership which is approximately 3.514%.
